Introduction
We have detected several genetic variants of CASP1 in patients suffering from unexplained recurrent febrile episodes. Paradoxically, in vitro and in vivo analyses of patients' cells revealed decreased enzymatic activity of these caspase-1 variants leading to impaired cytokine production despite the proinflammatory phenotype of the patients. The pathophysiological processes associated with CASP1 variants are still under investigation.
Objectives
In order to recapitulate the effects of the CASP1 mutations found in the patients we tried to establish a bacterial artificial chromosome (BAC) transgenic mouse line expressing enzymatically inactive Casp1 C284A under the control of the own promoter.
Methods
The purified BAC fragment containing Flag-tagged Casp1 C284A (Casp1 C284AFlag ) was injected into the pronuclei of fertilized C57Bl6 mouse oocytes, followed by transfer of these oocytes to pseudopregnant foster mothers. Pups born from these mothers were analyzed for the presence of full-length Casp1 C284AFlag by screening with sequence specific PCR, Southern blot, and sequencing of the transgene. Casp1 C284AFlag transgenic mice were crossed to conventional Casp1 knock-out (KO) mice and the immunological phenotype of the progeny was analyzed by in vitro stimulation of BMDCs. Expression levels of the Casp1 C284AFlag transgene were quantified by qRT-PCR and Western blots. Released cytokine levels were determined by cytometric bead arrays.
Results
From two independent pronucleus injections we received 180 pups. Only three of them harbored transgene sequences and only one female animal proved to harbor the complete Casp1 C284AFlag transgene (TG). Crossing to Casp1 KO mice yielded the following genotypes: Casp1WT/WT/TG, Casp1WT/KO/TG, and Casp1KO/ KO/TG. qRT-PCR analyses revealed that unstimulated Casp1 C284AFlag transcription was reduced to 0.1% of wildtype Casp1. Hence, protein expression could not be detected in unstimulated cells. However, stimulation with LPS upregulated transcription and low-level translation of Casp1 C284AFlag in BMDCs. Determination of released cytokines after LPS/ATP stimulation revealed increased release of IL-6 and TNF-a from Casp1WT/KO/TG mice with proven Casp1 C284AFlag expression.
Conclusion
These data indicate that even tiny amounts of Casp1 C284A-Flag induced release of other proinflammatory cytokines and that this might contribute to the proinflammatory phenotype observed in our patients. Baseline expression of enzymatically inactive Casp1 C284AFlag may be embryonically lethal in mice since not a single mouse could be generated which expressed the transgene under unstimulated conditions. Hence, a conditional Casp1 C284AFlag knock-in mouse model is being established.
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